Stay updated on Glioblastoma Treatment Clinical Trial
Sign up to get notified when there's something new on the Glioblastoma Treatment Clinical Trial page.

Latest updates to the Glioblastoma Treatment Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew revision notes (v3.4.2) and date entries were added (2026-02-06, 2027-12, 2026-01-20). Older revision notes (v3.4.1) and past dates (2025-10-28, 2025-12, 2025-10-10) were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page shows a revision from v3.4.0 to v3.4.1, which appears to be a backend/structural update with no visible changes to study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded a glossary toggle and QC-related labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with a revision stamp (v3.4.0). Removed the lowercase variants (Last Update Submitted that met QC Criteria, No FEAR Act data) and the older revision label (v3.3.4).SummaryDifference0.2%

- Check43 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page, a minor update with no visible changes to core study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Florida to the Locations section and removed the separate Florida Locations entry along with the HHS Vulnerability Disclosure from the page.SummaryDifference0.2%

- Check93 days agoChange DetectedThe additions indicate that PubMed publications for the study are auto-filled and show Revision: v3.3.2; the previous PubMed note and Revision: v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Glioblastoma Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glioblastoma Treatment Clinical Trial page.